Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 2 de 2
Add filters

Document Type
Year range
J Parkinsons Dis ; 10(4): 1343-1353, 2020.
Article in English | MEDLINE | ID: covidwho-982796


Since the initial reports of COVID-19 in December 2019, the world has been gripped by the disastrous acute respiratory disease caused by the SARS-CoV-2 virus. There are an ever-increasing number of reports of neurological symptoms in patients, from severe (encephalitis), to mild (hyposmia), suggesting the potential for neurotropism of SARS-CoV-2. This Perspective investigates the hypothesis that the reliance on self-reporting of hyposmia has resulted in an underestimation of neurological symptoms in COVID-19 patients. While the acute effect of the virus on the nervous system function is vastly overshadowed by the respiratory effects, we propose that it will be important to monitor convalescent individuals for potential long-term implications that may include neurodegenerative sequelae such as viral-associated parkinsonism. As it is possible to identify premorbid harbingers of Parkinson's disease, we propose long-term screening of SARS-CoV-2 cases post-recovery for these expressions of neurodegenerative disease. An accurate understanding of the incidence of neurological complications in COVID-19 requires long-term monitoring for sequelae after remission and a strategized health policy to ensure healthcare systems all over the world are prepared for a third wave of the virus in the form of parkinsonism.

Coronavirus Infections/complications , Parkinsonian Disorders/psychology , Parkinsonian Disorders/virology , Pneumonia, Viral/complications , Agnosia/virology , COVID-19 , Coinfection/complications , Coronavirus Infections/psychology , Humans , Pandemics , Pneumonia, Viral/psychology
J Parkinsons Dis ; 10(4): 1383-1388, 2020.
Article in English | MEDLINE | ID: covidwho-721453


The coronavirus disease 2019 (COVID-19) pandemic has upended daily life and neurologic care for most patients, including those with Parkinson's disease and parkinsonism. Disruptions to routine care, high volumes of patient and caregiver calls, and our patients' risk of infection and complications inspired a proactive COVID-19 outreach program. This program targets patients with advanced Parkinson's disease and related disorders, specifically those who are homebound, receiving or eligible for palliative care, and/or lacking support networks. We describe the program and practical strategies providers can implement to support wellbeing and successful telehealth uptake during this time of social isolation and gradual reopening.

Coronavirus Infections , Pandemics , Parkinsonian Disorders/nursing , Pneumonia, Viral , Telemedicine/methods , COVID-19 , Humans , Parkinsonian Disorders/psychology , Social Isolation